{"id":"diet-pravastatin","safety":{"commonSideEffects":[{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":{"chemblId":"CHEMBL1144","moleculeType":"Small molecule","molecularWeight":"424.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Pravastatin is a competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby reducing LDL cholesterol levels. The dietary component complements this pharmacological effect by reducing dietary cholesterol and saturated fat intake. Together, this combination approach addresses both endogenous and exogenous sources of cholesterol elevation.","oneSentence":"A combination therapy that uses dietary intervention alongside pravastatin, a statin that inhibits HMG-CoA reductase to lower cholesterol synthesis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:35:15.064Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"},{"name":"Cardiovascular disease prevention"}]},"trialDetails":[{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT03510884","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-05-31","conditions":"Hypercholesterolaemia","enrollment":153},{"nctId":"NCT05107063","phase":"","title":"An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2016-01-20","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2972},{"nctId":"NCT03510715","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-08-31","conditions":"Hypercholesterolemia","enrollment":18},{"nctId":"NCT01890967","phase":"PHASE2","title":"A Study of LY3015014 in Participants With High Cholesterol","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Hypercholesterolemia","enrollment":527},{"nctId":"NCT00000542","phase":"PHASE3","title":"Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1993-08","conditions":"Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus","enrollment":""},{"nctId":"NCT00000539","phase":"PHASE3","title":"Arterial Disease Multifactorial Intervention Trial (ADMIT)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1992-09","conditions":"Arterial Occlusive Diseases, Cardiovascular Diseases, Heart Diseases","enrollment":""},{"nctId":"NCT00000461","phase":"PHASE2","title":"Harvard Atherosclerosis Reversibility Project (HARP)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1986-12","conditions":"Cardiovascular Diseases, Coronary Disease, Heart Diseases","enrollment":""},{"nctId":"NCT00794963","phase":"NA","title":"Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia","status":"TERMINATED","sponsor":"Northwell Health","startDate":"2008-11","conditions":"Metabolic Syndrome","enrollment":8},{"nctId":"NCT00718796","phase":"PHASE3","title":"Naturopathic Treatment for the Prevention of Cardiovascular Disease","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2008-04","conditions":"Cardiovascular Disease","enrollment":300},{"nctId":"NCT00688922","phase":"PHASE4","title":"Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study","status":"UNKNOWN","sponsor":"Osaka Acute Coronary Insufficiency Study Group","startDate":"2008-07","conditions":"Acute Myocardial Infarction","enrollment":400},{"nctId":"NCT00211705","phase":"PHASE4","title":"Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)","status":"COMPLETED","sponsor":"Mitsukoshi Health and Welfare Foundation","startDate":"1994-02","conditions":"Hyperlipidemia","enrollment":8000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Diet+pravastatin","genericName":"Diet+pravastatin","companyName":"Mitsukoshi Health and Welfare Foundation","companyId":"mitsukoshi-health-and-welfare-foundation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A combination therapy that uses dietary intervention alongside pravastatin, a statin that inhibits HMG-CoA reductase to lower cholesterol synthesis. Used for Hypercholesterolemia, Cardiovascular disease prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}